Showing results (1-10 of 203) with videos related to
Sort By:
Pageof 21
The Medical Journal of Australia|March 6, 1976
Plasma drug concentrations in therapeuticsW D Hooper, J H Tyrer, M J EadieClinical and Experimental Pharmacology & Physiology|May 1, 1976
The elimination of phenytoin in manM J Eadie, J H Tyrer, F Bochner, et al.Journal of Neurology, Neurosurgery, and Psychiatry|October 1, 1972
Effect of a delayed-action phenytoin preparation on blood phenytoin concentrationF Bochner, W D Hooper, J H Tyrer, et al.Journal of Neurology, Neurosurgery, and Psychiatry|December 1, 1972
Effect of dosage increments on blood phenytoin concentrationsF Bochner, W D Hooper, J H Tyrer, et al.Australian and New Zealand Journal of Medicine|October 1, 1975
Decreased capacity to metabolize diphenylhydantoin in a patient with hypersensitivity to warfarinF Bochner, W D Hooper, M J Eadie, et al.Clinical and Experimental Neurology|January 1, 1978
Preliminary observations on the pharmacokinetics of methylphenobarbitoneM J Eadie, F Bochner, W D Hooper, et al.Journal of Neurology, Neurosurgery, and Psychiatry|October 1, 1974
Buccal absorption of ergotamineJ M Sutherland, W D Hooper, M J Eadie, et al.British Medical Journal|October 31, 1970
Outbreak of anticonvulsant intoxication in an Australian cityJ H Tyrer, M J Eadie, J M Sutherland, et al.British Journal of Clinical Pharmacology|October 1, 1977
Factors influencing plasma phenobarbitone levels in epileptic patientsM J Eadie, C M Lander, W D Hooper, et al.Proceedings of the Australian Association of Neurologists|January 1, 1976
The effects of phenobarbitone dose on plasma phenobarbitone levels in epileptic patientsM J Eadie, C M Lander, W D Hooper, et al.Pageof 21